[{"id":"1352226f89eff4784407fd936bb018f290d813c63437bca3b21f07a928060983","drugName":"CHEMBL2105708","diseaseName":"EFO_1000131","maxClinicalStatus":"PHASE_2","mappingStatus":"FULLY_MAPPED","diseaseId":"EFO_1000131","drugId":"CHEMBL2105708","clinicalReportIds":["NCT03576547","NCT01424982"],"mappingConfidence":"automatic"},{"id":"a621017ebebcb9a13ffd870e703e2162c991b954ed65da2fc09c00debc5dcd08","drugName":"CHEMBL2105708","diseaseName":"EFO_0000220","maxClinicalStatus":"APPROVED","mappingStatus":"FULLY_MAPPED","diseaseId":"EFO_0000220","drugId":"CHEMBL2105708","clinicalReportIds":["NCT02779283","NCT01424982","807f988e-117b-4497-934d-73aa78baac71","97/ponatinib hydrochloride/acute lymphoblastic leukemia"],"mappingConfidence":"automatic"},{"id":"fc8f427316f581b21c4967b45f1c502bc87a30cea01074a8ca57ddc6a139b6cb","drugName":"CHEMBL2105708","diseaseName":"EFO_0000222","maxClinicalStatus":"PHASE_1","mappingStatus":"FULLY_MAPPED","diseaseId":"EFO_0000222","drugId":"CHEMBL2105708","clinicalReportIds":["NCT02779283"],"mappingConfidence":"automatic"},{"id":"31c4c3dd5ac7fa2ba2c802ba23801b79926284ab24a010674cd8910b165da93b","drugName":"CHEMBL2105708","diseaseName":"EFO_0000565","maxClinicalStatus":"NO_DEVELOPMENT_REPORTED","mappingStatus":"FULLY_MAPPED","diseaseId":"EFO_0000565","drugId":"CHEMBL2105708","clinicalReportIds":["NCT02981784"],"mappingConfidence":"automatic"},{"id":"c712c51b34c5bea20843c50ce2b42f74b531d969df66df7c5e1b388f905ed485","drugName":"CHEMBL2105708","diseaseName":"EFO_0000339","maxClinicalStatus":"APPROVED","mappingStatus":"FULLY_MAPPED","diseaseId":"EFO_0000339","drugId":"CHEMBL2105708","clinicalReportIds":["807f988e-117b-4497-934d-73aa78baac71","16d804b6-4957-43ee-b18c-3b36ec37c5ac","97/ponatinib hydrochloride/chronic myelogenous leukemia"],"mappingConfidence":"automatic"},{"id":"794643e1e56028ad1c272befdf106b138ff4947b5732657d15687029196a8f78","drugName":"CHEMBL2105708","diseaseName":"MONDO_0004992","maxClinicalStatus":"PHASE_2","mappingStatus":"FULLY_MAPPED","diseaseId":"MONDO_0004992","drugId":"CHEMBL2105708","clinicalReportIds":["NCT02272998"],"mappingConfidence":"automatic"},{"id":"85a2811802c1ee6432c61a227745967a02143af949425c24bee701ffdf9a0ef9","drugName":"CHEMBL2105708","diseaseName":"MONDO_0002691","maxClinicalStatus":"PHASE_2","mappingStatus":"FULLY_MAPPED","diseaseId":"MONDO_0002691","drugId":"CHEMBL2105708","clinicalReportIds":["NCT02265341"],"mappingConfidence":"automatic"},{"id":"47f1f2f8c618ce86fbdfe8699725a882f7a1d6d8b38b7a784039e4d96054729c","drugName":"CHEMBL2105708","diseaseName":"EFO_1001755","maxClinicalStatus":"PHASE_2","mappingStatus":"FULLY_MAPPED","diseaseId":"EFO_1001755","drugId":"CHEMBL2105708","clinicalReportIds":["NCT01424982"],"mappingConfidence":"automatic"},{"id":"48ea74a3042f36eb0cc17a99b04074d9ec483c50d5eb191d2667ce89d39656aa","drugName":"CHEMBL2105708","diseaseName":"EFO_1001779","maxClinicalStatus":"PHASE_2","mappingStatus":"FULLY_MAPPED","diseaseId":"EFO_1001779","drugId":"CHEMBL2105708","clinicalReportIds":["NCT01620216"],"mappingConfidence":"automatic"}]